About the Authors

Annemarie Jutel

To whom correspondence should be addressed. E-mail: jutel@clear.net.nz

David B Menkes

Competing Interests

Annemarie Jutel previously held shares in Pfizer, but sold them during the preparation of this work. David Menkes has accepted speakers' fees and support to attend conferences from various pharmaceutical companies. In addition, he has received research support from Roche, Eli Lilly, and Lundbeck, and has served as an expert witness on behalf of plaintiffs in civil cases defended by Eli Lilly, GlaxoSmithKline, and Pfizer.

Author Contributions

AJ conceived the project and wrote the initial draft of the paper. DBM provided resources and material for review and reviewed the research material and conclusions. Both authors played an equal part in editing and revising the paper.